The Healthier Basket: How a $6.16 Trillion Wellness Market Is Rewriting the CPG Playbook

Wellness is no longer a category on the shelf. It is the logic that decides what goes into the basket, what premium shoppers will pay, and which brands big companies choose to buy. This is what that means for consumer packaged goods.

Why the wellness boom is really a CPG story

The Cervicorn Consulting Expert Panel estimates the global health and wellness market at $6.16 trillion in 2025, rising above $10.14 trillion by 2035. That is a compound annual growth rate (CAGR) of 5.11% from 2026 to 2035 and nearly $4 trillion of additional annual spending. Services, devices and clinics will take a share. But the first and most frequent touchpoint for wellness spending is still a packaged product: the yogurt with added protein, the prebiotic soda, the fibre cereal, the electrolyte sachet, the vitamin gummy.

For CPG companies this creates an unusual combination of opportunity and pressure. Demand is moving toward products that claim a health benefit and can prove it, yet the core of many portfolios was built for taste, convenience and price. This article looks at where the pressure is greatest, where the growth is concentrated, and how global and Indian players are responding.

Exhibit 1: The market CPG is competing for

The claim premium: health-led products pull ahead

The clearest evidence that wellness is a CPG growth engine comes from retail scan data. NielsenIQ (NIQ), tracking US food and beverage, found that products carrying better-for-you claims grew sales at a compound rate of 6.4% a year between 2018 and 2022, against 4.7% for products without such claims, a gap of 170 basis points. The period predates the latest surge in protein and GLP-1 related demand, which suggests the premium has been building for years.

Growth is also concentrated. In a 2026 NIQ analysis, just 4.5% of US households accounted for 43% of the sales growth in products carrying muscle health claims. These are the over-informed shoppers who scan labels, compare ingredient panels and look for proof before they buy. For a brand, winning this small group first can matter more than broad distribution.

Exhibit 2: Claims, and the households behind the growth

Table 1: Where shopper signals are strongest

The squeeze on the middle of the shelf

Wellness is rising at the same time as a structural shift in price tiers. Across 26 measured markets, NIQ reports that the mainstream tier's share of global CPG value sales fell by one percentage point to 43% in the year to 14 June 2026. Premium gained 0.6 points to 40% and discount gained 0.3 points to 18%. The middle is being squeezed from both ends.

Exhibit 3: Mainstream is losing share to both ends

 
This matters for wellness because a credible health position is one of the few justifications for a premium price that shoppers accept even when budgets are tight. It also changes who can win. NIQ's earlier analysis of the US better-for-you segment found that small and medium manufacturers were growing fastest, even though large manufacturers hold most of total food and beverage sales. Scale is helpful, but it is not decisive in a market where proof, focus and speed to a new claim carry weight.

Buy, build or fade: wellness dealmaking in CPG

Large CPG groups have answered the pressure with their chequebooks. In 2025 alone, PepsiCo agreed to buy prebiotic soda brand poppi for $1.95 billion, Celsius bought Alani Nu for about $1.8 billion, Keurig Dr Pepper took a 60% stake in Ghost for a reported $990 million, and private equity firm Gryphon bought sparkling water brand Spindrift for roughly $650 million. Flowers Foods added Simple Mills to its better-for-you range.

Exhibit 4: Big CPG is buying its way into wellness

Table 2: What the buyers were really purchasing

The deals share a pattern. Acquirers are buying proven consumer relationships and credible health positioning, then adding their own distribution. The risk is that the claim does not survive scrutiny. In 2025, poppi agreed to an $8.9 million settlement fund for consumers amid litigation over its health positioning, a reminder that buyers inherit claim risk along with brand equity.

GLP-1 and the pantry: smaller baskets, higher standards

GLP-1 weight-management medicines have turned a pharmaceutical trend into a category force. FTI Consulting's spring 2026 survey found that about 18% of US adults use a GLP-1 drug, up from around 14% a year earlier, and estimates that about $95 billion of US packaged food spend is at risk by 2030 under current trajectories. A Cornell University study found that households cut grocery spending by an average of 5.3% within six months of adoption.

The effect is not uniform. Users are trading out of indulgence categories and into protein, produce and portion-controlled formats, and CPG companies have started to respond with dedicated lines and labels.

Table 3: The GLP-1 effect on CPG categories

Dietitians cited in Indian business media warn that a GLP-1 label can become a marketing phrase. The sustainable play is to publish clear protein, fibre and sugar numbers and let shoppers judge, rather than rely on a badge that any competitor can copy.

Discovery moves to the algorithm and the app

The path to purchase for wellness products now runs through search, retailer apps and chatbots as much as through the aisle. NIQ data for the UK show e-commerce as the fastest-growing FMCG channel, with value growth of 9.0% and a market share of 14.2% in early 2026. A joint NIQ and Kearney analysis reports that challenger brands are gaining share as AI reshapes innovation and product discovery.

Consumers also lean on AI for health questions. KFF found that about 32% of US adults used AI for health information in the past year, yet West Health and Gallup polling suggests only about a third of recent users trust its accuracy. For CPG brands the lesson is practical. Ingredient panels, claim substantiation and nutrition data must be machine-readable and consistent across every listing, because an inconsistent label is both a trust problem and a ranking problem.

India: from health foods niche to FMCG roadmap

India's FMCG leaders have moved wellness from the margins to the centre of their innovation plans. Tata Consumer Products, for example, anchors innovation on five health platforms: gut health, metabolic health, iron fortification, protein and sugar reduction. In its 2025-26 annual report, health and wellness made up 55% of its 80 new launches, 44 in total. Its growth businesses expanded 40% in the second quarter of FY27 and now account for 38% of its India business, while coffee grew about 20% and ready-to-drink beverages about 23% in recent quarters.

Exhibit 5: Wellness shapes the India FMCG roadmap

Table 4: How Indian CPG is moving

Three features set India apart. First, protein is being mainstreamed through staples such as atta, dairy and snacks, not just supplements; IMARC Group sizes India's protein supplements market at $912.9 million in 2025, growing at 6.27% a year to 2034. Second, acquisitions are crossing industry lines, with pharma and personal care companies buying nutrition brands. Third, one industry executive quoted in trade media described the nutraceutical sector as growing 10% to 12% a year, a pace that attracts FMCG groups with slower core categories.

The Cervicorn Claim-to-Cart framework

Pulling the evidence together, we propose a simple framework for CPG leaders. A wellness claim only becomes revenue when four disciplines work in sequence: Proof, Portfolio, Price and Placement.

Exhibit 6: The Cervicorn Claim-to-Cart framework

Table 5: Applying Claim-to-Cart

A screen for investors and acquirers

• Is the claim backed by evidence that would survive litigation or a regulator's review?
• Does revenue depend on one shopper segment, one retailer or one ingredient trend?
• Can the brand hold price when the middle tier is under pressure?
• Will the product still make sense in a GLP-1 world of smaller portions?

Risks to watch

• Claim liability. Functional and health claims invite scrutiny from regulators, plaintiffs and increasingly from AI systems that repeat criticisms.
• Volume erosion. GLP-1 adoption can shrink volumes in snacks, sweets and quick-service categories faster than new lines can replace them.
• Hype cycles. Prebiotic sodas, protein add-ons and similar trends can attract crowded entry and margin compression.
• Definition drift. Market sizes differ by scope. Brands should anchor plans on a consistent definition of their addressable market.
• Data and privacy. Personalised nutrition depends on shared health data, and many consumers remain concerned about how it is used.

Conclusion

A $6.16 trillion market growing past $10 trillion is not a trend for CPG to watch. It is the environment in which every portfolio now operates. The shelf is shifting toward claims that can be verified, price tiers are polarising, deals are consolidating credible brands, and discovery is moving to places where a label must speak for itself.

The Claim-to-Cart framework offers a practical test. For every product, ask whether the proof is real, the portfolio fits the need, the price feels earned and the brand can be found where the decision happens. Companies that can answer yes on all four will turn wellness from a marketing theme into a durable source of growth.

For research inquiries covering the humanoid robot market, robotics technologies, competitive intelligence, market entry strategies, and industry opportunities, contact sales@cervicornconsulting.com.